Penn State Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
NCT Number: NCT02118974
Robotic-assisted surgery is becoming more prominent within the specialty of Gynecologic surgery with little direct evidence that it is if not better than traditional laparoscopic surgery, at least equivalent. We designed a randomized-controlled trial to compare operative times, length of hospital stay, estimated blood loss, and post-operative complications associated with these two methods of minimally invasive hysterectomy.
Looking for future studies?
Notify Me18 year–80 year
Female
Interventional
Not applicable
Hershey, Pennsylvania, 17033, United States
The proposed study will be a non-blinded randomized control trial. Patients will be randomized into each group Conventional Laparoscopic Hysterectomy (Group #1) and Robot-Assisted Laparoscopic Hysterectomy (Group #2) using a random number generator. Data collection will occur during the following points of patient interaction: pre-operative appointment, the surgical procedure, the patient's hospitalization, first post-operative appointment, and final post-operative appointment.
The care for the patients enrolled in this study will not deviate from the standard care of patients who are currently undergoing laparoscopic and robot-assisted laparoscopic hysterectomy. The patients who present to the office for pre-operative history and physical examination for laparoscopic hysterectomy will be counseled about participation in this study. Basic data collection will commence at the pre-operative visiting, including: patient demographics, past medical history, past surgical history, physical exam findings, and imaging results. The pre-operative appointment will occur between one to thirty days prior to surgery. Intra-operative and immediate post-operative data will be collected by the surgical assistant (resident or fellow) and will include surgical procedure (conventional laparoscopic or robot-assisted), operative time, hematocrit, estimated blood loss, length of stay, and complications.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hysterectomy
Time frame: Intra operative
The primary end point is difference in operative time
Time frame: up to 6 weeks following intervention
Complications related to the procedure including delays in discharge and re-admissions will be monitored and evaluated individually throughout the study.
Milton S. Hershey Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01793584
Adenomyosis, Adnexal Diseases
Dallas, Texas, United States
View Trial DetailsNCT03670680
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Bron, France
View Trial DetailsNCT04267562
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Newburgh, Indiana, United States
View Trial DetailsNCT03751800
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Many Locations, Spain
View Trial Details